Glaucoma linked to increased risk of dementia
Medical researchers have found a link between a type of glaucoma and an increased risk of developing dementia, according to a new study published in the […]
New light on glaucoma gene discoveries
Globally 78 million people have glaucoma. That is one in every 200 people aged 40, which rises to one in eight by age 80 – and […]
New research preventing blindness in Indigenous communities
Early detection, increased screening and improved treatment options that combat diabetic retinopathy (DR), a leading cause of blindness in South Australian Aboriginal communities, is the aim […]
New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person’s risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at […]
Seeking answers to sleep, vision and gut disorders
Increasing levels of poor sleep and sleep disorders affects at least one in five Australians, leading to an estimated $66 billion a year in lost productivity […]
Renewed focus on predicting glaucoma risk
Confirmation of 40 new genetic markers takes forward the development of the first tests to assess a person’s risk of developing glaucoma, a leading cause of […]
Top award for world-leading glaucoma research
Flinders is at the forefront of finding solutions for glaucoma, the leading cause of irreversible blindness worldwide. By 2020, glaucoma will affect 80 million people worldwide, […]
$24.6m boost for medical research
From diabetes, cancer and heart disease to chronic pain and major depression, 12 new research grants announced today cap off a big year for Flinders medical […]
Gene discovery sheds light on childhood glaucoma
Ophthalmology experts at Flinders have played a pivotal role in discovering a new genetic cause for primary congenital glaucoma – a leading cause of blindness in children.